US Stock MarketDetailed Quotes
ADTX Aditxt
- 0.5299
- -0.0251-4.52%
Close Nov 1 16:00 ET
- 0.5290
- -0.0009-0.17%
Post 19:59 ET
4.63MMarket Cap0.00P/E (TTM)
0.5598High0.5101Low2.42MVolume0.5300Open0.5550Pre Close1.29MTurnover27.72%Turnover Ratio0.00P/E (Static)8.74MShares380.000052wk High0.71P/B4.63MFloat Cap0.505052wk Low--Dividend TTM8.74MShs Float766400.0000Historical High--Div YieldTTM8.96%Amplitude0.5050Historical Low0.5300Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Aditxt Stock Forum
fight boy 🦍🦍🦍
Aditxt's Target Acquisition Appili Therapeutics Announces Alignment With FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
Aditxt (NASDAQ: ADTX) has announced a significant development regarding its target acquisition, Appili Therapeutics (TSX: APLI; OTCPink: APLIF). The U.S. Food and Drug Administration (FDA) has provided positive feedback on the development strategy for ATI-1801, Appili's topical antiparasitic product. This feedback...
No comment yet